Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer Academic Article uri icon

Overview

MeSH Major

  • Lymph Node Excision
  • Lymph Nodes
  • Neoplasm, Residual
  • Neoplasms, Germ Cell and Embryonal
  • Testicular Neoplasms

abstract

  • Our data suggest that teratoma or viable NSGCT is present in approximately one-third of patients undergoing resection of residual ERP disease. The presence of residual ERP teratoma and viable NSGCT predicts for cancer progression independent of RP histology.

publication date

  • January 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.urology.2011.09.038

PubMed ID

  • 22202548

Additional Document Info

start page

  • 156

end page

  • 9

volume

  • 79

number

  • 1